Hepatology
Signal score, how each part rates
ActionabilityPrevalenceStakesEvidence strengthNovelty
See the full rubric →Oral Anticoagulant Choice Across Indications in Cirrhosis: A US Nationwide Cohort Study.
Clinical takeawayThese propensity-matched associations support indication-specific anticoagulant choice in cirrhosis: in AF, DOACs were associated with less bleeding at similar mortality; in DVT/PE or PVT, DOAC initiators had higher mortality and lower transplant access than warfarin initiators.
What it foundAmong 93,663 initiators, DOACs vs warfarin in AF were associated with similar mortality and transplant rates and lower major and non-gastrointestinal bleeding, including intracranial hemorrhage. In DVT/PE and PVT, DOACs were associated with higher mortality (sHR 1.21 [95% CI 1.10-1.34] and 1.43 [1.24-1.65]) and lower transplant rates (sHR 0.25 [0.17-0.38] and 0.23 [0.17-0.32]); gastrointestinal bleeding was higher with DOACs in PVT (sHR 1.26 [1.06-1.50]).
ContextPartly an allocation effect: in a waitlisted cohort (n=284), warfarin-related INR elevation, which inflates MELD, mediated 29% of the transplant-access difference; the authors call for reconsidering INR handling in US transplant allocation.
No standard claimed for this paper
Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.
Tanaka T … Axelrod D · Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association · IF 16.2 · PubMed ↗